Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (571-580 of 611) with videos related to

Pageof 62
Sort By:
The Lancet. Oncology|November 3, 2015
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic studyTakaya Moriyama, Monika L Metzger, Gang Wu, et al.
Nature Genetics|February 16, 2016
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicityTakaya Moriyama, Rina Nishii, Virginia Perez-Andreu, et al.
The New England Journal of Medicine|November 19, 2015
Germline Mutations in Predisposition Genes in Pediatric CancerJinghui Zhang, Michael F Walsh, Gang Wu, et al.
Nature Communications|June 25, 2015
Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in childrenHeng Xu, Hui Zhang, Wenjian Yang, et al.
The Journal of Molecular Diagnostics : JMD|August 13, 2022
Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic LeukemiaChih-Hsiang Yu, Gang Wu, Chia-Ching Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2022
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II TrialTianyi Wang, Yanjing Tang, Jiaoyang Cai, et al.
Blood|February 22, 2022
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaShunsuke Kimura, Lindsey Montefiori, Ilaria Iacobucci, et al.
Blood Advances|April 21, 2022
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C Talleur, Amr Qudeimat, Jean-Yves Métais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2024
Reply to: Accurate Determinants of Outcome in ALLTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Genomic Determinants of Outcome in Acute Lymphoblastic LeukemiaTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
Pageof 62

Showing results (571-580 of 611) with videos related to

Sort By:
Pageof 62
The Lancet. Oncology|November 3, 2015
Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic studyTakaya Moriyama, Monika L Metzger, Gang Wu, et al.
Nature Genetics|February 16, 2016
NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicityTakaya Moriyama, Rina Nishii, Virginia Perez-Andreu, et al.
The New England Journal of Medicine|November 19, 2015
Germline Mutations in Predisposition Genes in Pediatric CancerJinghui Zhang, Michael F Walsh, Gang Wu, et al.
Nature Communications|June 25, 2015
Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in childrenHeng Xu, Hui Zhang, Wenjian Yang, et al.
The Journal of Molecular Diagnostics : JMD|August 13, 2022
Sequential Approach to Improve the Molecular Classification of Childhood Acute Lymphoblastic LeukemiaChih-Hsiang Yu, Gang Wu, Chia-Ching Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 8, 2022
Coadministration of CD19- and CD22-Directed Chimeric Antigen Receptor T-Cell Therapy in Childhood B-Cell Acute Lymphoblastic Leukemia: A Single-Arm, Multicenter, Phase II TrialTianyi Wang, Yanjing Tang, Jiaoyang Cai, et al.
Blood|February 22, 2022
Enhancer retargeting of CDX2 and UBTF::ATXN7L3 define a subtype of high-risk B-progenitor acute lymphoblastic leukemiaShunsuke Kimura, Lindsey Montefiori, Ilaria Iacobucci, et al.
Blood Advances|April 21, 2022
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C Talleur, Amr Qudeimat, Jean-Yves Métais, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2024
Reply to: Accurate Determinants of Outcome in ALLTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 9, 2024
Genomic Determinants of Outcome in Acute Lymphoblastic LeukemiaTi-Cheng Chang, Wenan Chen, Chunxu Qu, et al.
Pageof 62